Montelukast Prescribing at DR I RASIB & PARTNERS
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
860
Total Quantity
26.2K
NHS Cost
£1.3K
vs National Avg
+25.6%
DR I RASIB & PARTNERS prescribed 860 items of Montelukast over the last 12 months at a cost of £1,275 to the NHS. This is 25.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
87
Jul 2026
62
Jul 2026
77
Jul 2026
65
Jul 2026
84
Jul 2026
68
Jul 2026
73
Jul 2026
77
Jul 2026
74
Jul 2026
69
Jul 2026
64
Jul 2026
60
Prescribing Details
| Total Items | 860 |
|---|---|
| Total Quantity | 26,208 |
| Total NHS Cost | £1,275 |
| Presentations | 4 different forms |
| vs National Average | +25.6% |
Montelukast Prescribing Comparison
| This practice | 860 items |
|---|---|
| National average per practice | 685 items |
| Difference | +25.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.